Concepedia

Clinical Utility of Change in Nonalcoholic Fatty Liver Disease Activity Score and Change in Fibrosis in NAFLD

Nobuharu Tamaki, Nagambika Munaganuru, Jinho Jung, Aed Qas Yonan, Richele Bettencourt, Veeral Ajmera, Mark A. Valasek, Cynthia Behling, Rohit Loomba

Clinical Gastroenterology and Hepatology · 2020 · 18 citations · 4 references

DOIFull text

Open access

Concepts

References

4

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta et al. · Hepatology · 2005 · 10.7K citations

, , +16

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal et al. · The Lancet · 2014 · 2.2K citations

, , +14

Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease

David E. Kleiner, Elizabeth M. Brunt, Laura Wilson et al. · JAMA Network Open · 2019 · 367 citations · Full text

, , +17

Multicenter Validation of Association Between Decline in MRI‐PDFF and Histologic Response in NASH

Rohit Loomba, Brent A. Neuschwander‐Tetri, Arun J. Sanyal et al. · Hepatology · 2020 · 143 citations · Full text

, , +17